Understanding The GLP-1 Phenomenon And The Need For Metabolic Clarity
As we enter 2026, the weight loss industry is in the midst of a massive identity crisis. On one side, pharmaceutical companies are pushing GLP-1 receptor agonists like semaglutide as the only solution for obesity. On the other hand, thousands of patients are reporting “buyer’s remorse” as they navigate the reality of long-term dependency and […]
Understanding The GLP-1 Phenomenon And The Need For Metabolic Clarity Read More »
